General Information of the Compound
| Compound ID |
CP0501149
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3S,4S)-N-benzyl-3-fluoro-N-methyl-1-[3-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]propyl]piperidin-4-amine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H31FN6
|
||||||||||||||||||
| Molecular Weight |
446.574
|
||||||||||||||||||
| Canonical SMILES |
CN(Cc1ccccc1)[C@H]1CCN(CCCc2c[nH]c3ccc(cc23)-n2cnnc2)C[C@@H]1F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H31FN6/c1-31(16-20-6-3-2-4-7-20)26-11-13-32(17-24(26)27)12-5-8-21-15-28-25-10-9-22(14-23(21)25)33-18-29-30-19-33/h2-4,6-7,9-10,14-15,18-19,24,26,28H,5,8,11-13,16-17H2,1H3/t24-,26-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UDCHGILOZYGNHW-AHWVRZQESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01202, 5-hydroxytryptamine receptor 1B
Protein ID: PT00827, 5-hydroxytryptamine receptor 1D